PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus

NEXT STORY
Valeo Pharma Announces $10 Million Bought Deal Private Placement of Convertible Debentures With Concurrent $10 Million Private Placement From Investissement Quebec
PREV STORY
Insights on the Animal Vaccines Global Market to 2028 – Size, Share & Trends Analysis Report
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Exagen Points the Way for Patients with Difficult-to-Diagnose Disease

May is Lupus Awareness Month San Diego, Ca and Albuquerque, NM, May 02, 2018 ...

author_avatar
NASDAQ Market News

Immunomedics Appoints Michael R. Garone as New Chief Financial Officer

MORRIS PLAINS, N.J., June 21, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced ...

author_avatar
NASDAQ Market News

NeuroMetrix Reports Publication of Randomized Controlled Trial of Quell Wearable Pain Relief in Chronic Low Back Pain

WALTHAM, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of ...

author_avatar
NASDAQ Market News